冠状动脉介入治疗期间肝素抗凝的最新进展。

Current interventional cardiology reports Pub Date : 1999-09-01

Narins

{"title":"冠状动脉介入治疗期间肝素抗凝的最新进展。","authors":"Narins","doi":"","DOIUrl":null,"url":null,"abstract":"Although the equipment, techniques, and adjunctive pharmacologic agents used during coronary angioplasty have evolved dramatically over the past 20 years, unfractionated heparin remains a standard component of the procedure. This article reviews recent data and current concepts regarding the use, importance, and proper dosing of heparin during percutaneous coronary intervention, especially when concomitant platelet glycoprotein IIb/IIIa receptor antagonist therapy is used.","PeriodicalId":80270,"journal":{"name":"Current interventional cardiology reports","volume":"1 3","pages":"253-262"},"PeriodicalIF":0.0000,"publicationDate":"1999-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Update on Heparin Anticoagulation During Coronary Intervention.\",\"authors\":\"Narins\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although the equipment, techniques, and adjunctive pharmacologic agents used during coronary angioplasty have evolved dramatically over the past 20 years, unfractionated heparin remains a standard component of the procedure. This article reviews recent data and current concepts regarding the use, importance, and proper dosing of heparin during percutaneous coronary intervention, especially when concomitant platelet glycoprotein IIb/IIIa receptor antagonist therapy is used.\",\"PeriodicalId\":80270,\"journal\":{\"name\":\"Current interventional cardiology reports\",\"volume\":\"1 3\",\"pages\":\"253-262\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current interventional cardiology reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current interventional cardiology reports","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

尽管在过去的20年里，冠状动脉成形术中使用的设备、技术和辅助药物发生了巨大的变化，但未分离肝素仍然是该手术的标准组成部分。本文回顾了最近的数据和当前的概念，关于肝素在经皮冠状动脉介入治疗中的使用、重要性和适当剂量，特别是当同时使用血小板糖蛋白IIb/IIIa受体拮抗剂治疗时。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Update on Heparin Anticoagulation During Coronary Intervention.

Although the equipment, techniques, and adjunctive pharmacologic agents used during coronary angioplasty have evolved dramatically over the past 20 years, unfractionated heparin remains a standard component of the procedure. This article reviews recent data and current concepts regarding the use, importance, and proper dosing of heparin during percutaneous coronary intervention, especially when concomitant platelet glycoprotein IIb/IIIa receptor antagonist therapy is used.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current interventional cardiology reports

自引率

0.00%

发文量

期刊最新文献

Infectious Agents, Antibiotics, and Coronary Artery Disease. Local Drug Delivery During Percutaneous Coronary Intervention. Historical Aspects of Transcatheter Closure of the Patent Ductus Arteriosus. Summary and Comparison of Atrial Septal Defect Closure Devices. Restenosis: Relationship with Thrombosis.